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MANANGING ANESTHESIA FAILURES IN ENDODONTICS
Chadi Torbey* | Safwat Koumayha** | Jad Azzi*** | Claudia Dib****
Abstract
Local anesthesia is a safe, effective and reversible blocking of nerve impulses, with minor risks of irritation and allergic reactions,
which produces a loss of sensation in order to control pain. The challenge increases particularly in endodontic practice, to achieve
a deeper level of anesthesia that will last during the endodontic procedure. Successful management of pain and anxiety requires
knowledge of the anesthetic agents and the neuro-anatomy as well as a good control of the techniques.
The present paper is a review of techniques and molecules used in clinical practice to ensure a lasting analgesia for a pain-free
treatment.
Keywords: Anxiety - oral premedication - local anesthetic agents - intraosseous injection - inferior alveolar nerve block intrapulpal injection.
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GESTION DE L’ÉCHEC DE L'ANESTHÉSIE EN ENDODONTIE
Résumé
L’anesthésie locale est un blocage sûr, efficace et réversible de l’influx nerveux, à risques mineurs d’irritation et de réactions allergiques, qui produit une perte de sensation, afin de contrôler la douleur. Le défi augmente en particulier dans la pratique endodontique, pour obtenir un niveau profond de l’anesthésie qui va persister toute la durée du traitement endodontique.
Un contrôle réussi de la douleur et de l’anxiété nécessite la connaissance des propriétés des molécules anesthésiques, de la neuroanatomie et des techniques d’anesthésie.
Le présent document est une revue des techniques et des molécules utilisées dans la pratique clinique afin d’assurer une analgésie
durable pour un traitement sans douleur.
Mots-clés: anxiété – prémédiction – molécules anesthésiques – injection intra-osseuse – anesthésie intrapulpaire.
IAJD 2016;7(1):124-129.
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Introduction
With the progression of the carious
lesion and in the absence of treatment,
the bacteria may invade the pulp of the
tooth. Chronic inflammation spreads
out and the breakdown of damaged cell
membranes occurs releasing arachidonic acid (AA). An Acute exacerbation
manifests with an influx of neutrophils
and release of inflammatory mediators
(such as prostaglandins and interleukins) and proinflammatory neuropeptides (such as substance P, bradykinin,
and calcitonin gene-related peptide)
[1]. These mediators sensitize the peripheral nociceptors within the pulp of
the affected tooth, and increase pain
production and neuronal excitability
[2].
Lip numbness, probing the gingiva
around the tooth in question, or simply starting treatment and waiting for a
patient response are not very effective
in confirming whether the anesthesia
is achieved. Even when these symptoms were present, only 62% of the
patients had pulpal anesthesia [3].
More objective tests such as electric pulp tester (EPT) and/ or the application of a cold refrigerant on vital
tooth can be used before starting a clinical procedure. However, in a painful
vital tooth (with an irreversible pulpitis
(IP)), a negative response may not guarantee the pulpal anesthesia. A supplemental dose may be required if the
patient experiences pain when accessing the pulp chamber.
In multi-rooted teeth or plural
pulp systems in single rooted teeth,
the patient may still report pain
during treatment. Teeth with necrotic
pulp chamber, but whose root canals
contain vital tissue, may not be tested
using the above means. Testing for
pulpal anesthesia of the neighboring
teeth may give the clinician an indication of the anesthetic status of the
tooth to be treated [4].
Challenges exist in the mandibular
and the maxillary teeth, and missed
blocks (block failure) occurs because of
the individual variations in response to

the drug administered, operator differences, and variations of anatomy [5].
The most difficult teeth to anesthetize in case of IP are the mandibular
molars followed by mandibular premolars, then maxillary molars and premolars, and then mandibular anterior
teeth. Lesser problem in obtaining
anesthesia is encountered with maxillary anterior teeth.
In addition to anesthetic success
and failure, patients may also be
subject to slow onset of anesthesia
(more than 15min). It occurs about
19–27% of the time with the necessity
to re-administer the injection before
beginning treatment with no advantage for using a higher concentration
(1 : 50,000) of epinephrine in an inferior alveolar nerve block (IANB) [6], or
non-continuous anesthesia (episodes
of anesthesia followed by a lack of clinically detected anesthesia probably
related to the action of the anesthetic solution on the nerve membrane
blocking and unblocking of the sodium
channels). This occurs about 12–20%
of the time in mandibular teeth [7].
When the clinician is confronted
with the case of a severe IP in which
the conventional techniques failed, the
question arises about what strategies
can be applied to achieve a pain-free
root canal treatment.
Psychological treatment
Many patients suffer from anxiety
when remembering an unpleasant
injection or a painful root canal treatment. Anxiety is believed to play a
negative role by lowering the pain
threshold and thereby diminishing the
anesthetic effect.
A patient may not appreciate your
sophisticated skills but he is expert
in identifying a painless injection.
Dentists’ attitudes and behaviors
should reduce anxiety and conveys
professional competence [8]. Topical
agents can be used to temporarily
anesthetize the oral mucosa via the
tiny nerve endings located on its surfaces for the aim of reducing the discomfort of dental injections. In general,
it takes 1 to 5 minutes of contact time

on a dry surface even with concentrations higher than those of injectable
anesthetics [9]. Most of the widely
used topical anesthetics contacts use
20% benzocaine in various forms - gels,
ointments, sprays, and solutions - and
flavors such as strawberry, mint, cherry,
banana, and bubble gum. The 20%
benzocaine has no systemic absorption and combination agents for more
efficacies such as tetracaine, lidocaine,
and prilocaine are neither regulated
nor unregulated by the US Food and
Drug Administration (FDA) [10].
Oral premedication to improve
anesthesia
The administration of oral analgesics when treating patients suffering
from an IP to improve the success rate
of the anesthetic injection is a new
trend. Ianiro et al. studied the effect
of acetaminophen alone or combined
to ibuprofen with placebo; oral doses
were administered thirty minutes
before the IANB injection. Success
rate was 71.4% for the acetaminophen
group, 75.9% for the acetaminophen
and ibuprofen group, and 46.2% for the
placebo group. No significant differences were noted between the medication groups, but a higher success
compared to placebo [11].
Like nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen
has both central and peripheral
effects on prostaglandin synthesis.
While optimizing analgesia, acetaminophen-induced anti-nociception is
derived from synergism between peripheral, spinal, and supra-spinal sites.
Indiscriminate usage of this drug is
not warranted, and its administration
should be considered with great caution [12].
Galatin et al. used an intraosseous
(IO) injection of 40mg of methylprednisolone (Depo-Medrol*) and found
that it significantly reduced pain in
untreated patients diagnosed with IP.
Unfortunately, follow-up studies using
similar doses of methylprednisolone
failed to obtain the same results [13].
Another study in 2012 showed
that a pre-medication with 800mg
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Ibuprofen, 100mg Acetaminophen,
and 1000mg Paracetamol resulted in a
higher percentage of successful maxillary infiltration in case of IP [14]. The
preoperative use of oral dexamethasone increased the anesthetic success rate of the inferior alveolar nerve
block in patients having mandibular
molars diagnosed with asymptomatic IP [15]. However, a combination
dose of 1000 mg acetaminophen/10
mg hydrocodone given 60 minutes
before the administration of the IANB
did not result in a statistically significant increase in anesthetic success for
mandibular posterior teeth in patients
experiencing symptomatic IP [16].
The use of sedative agents and
their effect on success of analgesia in
patients diagnosed with IP was tested.
Lindemann found no significant difference between a sublingual dose of
Triazolam (0.25mg) and a placebo in
the success rate of IANB in emergency
cases of IP. He concluded that, with
conscious sedation, profound pulpal
anesthesia was still required to eliminate pain during endodontic treatment
of teeth with IP [17].
Changing the local anesthetic agents
Various local anesthetic agents
failed to show any difference in success
rates in either patients with normal
pulps or patients with IP [18], such as
3% mepivacaine (Carbocaine), 4% prilocaine, 4% prilocaine with 1:200,000
epinephrine, 2% mepivacaine with
1:20,000 levonordefrin and 4% articaine
with 1:100,000 epinephrine to 2% lidocaine with 1:100,000 epinephrine, lidocaine hydrocarbonate.
Bupivacaine has slower onset
compared to lidocaine but almost
the double of the duration of pulpal
anesthesia, i.e. approximately 4 hours.
Combined lidocaine/hyaluronidase
solution showed significant increase
in postoperative pain and trismus. The
success rate was not significantly different between a 3.6-ml volume and
a 1.8-ml volume of 2% lidocaine with
1:100,000 epinephrine to ensure complete pulpal anesthesia [19].

For mandibular posterior teeth,
a 4% buffered lidocaine formulation
did not result in a statistically significant increase in the success rate
or a decrease in pain injection of the
IANB in patients with symptomatic IP
[20]. Adding fentanyl (opioid medication- narcotic) to conventional local
anesthetic did not increase the effectiveness of infiltration in patients with
IP [21]. Buffering the 2% lidocaine with
1:80,000 epinephrine with 8.4% sodium
bicarbonate did not improve the success of the IANB in mandibular molars
in patients with symptomatic IP [22].
Changing the injection technique
Failure of profound anesthesia is
usually common in the IANB and especially when treating the first maxillary
molar.
In the mandible, neither the GowGates nor Vazirani-Akinosi (in case of
closed mouth) techniques have shown
an improved success rates when compared to the conventional IANB technique. Even though accurate injections could be achieved with the use
of ultrasound to guide an anesthetic
needle to its target, Hannan and colleagues [23] found that it did not result
in more successful pulpal anesthesia.
Needle deflection as related to the
needle bevel direction has also been
shown not to affect the anesthetic success rate of the IANB.
Accessory nerve block such as the
incisive nerve block at the mental foramen when combined with the inferior
alveolar nerve block demonstrated
an increased success rate in the first
molar.
The anaesthesia of the mylohyoid
nerve has been shown not to improve
success rate of the IANB [24].To overcome this accessory innervation, the
clinician has the options to deliver
anesthetic solution higher in the pterygomandibular space using the GowGates or the Akinosi techniques, or
proceed with a lingual infiltration on
the mandible regarding the tooth in
question [25].
For supplemental anesthesia,
intraosseous injection (IO) would be

a conceivable choice [26] since the
anesthetic solution is deposited right
in the medullary space at the apices of
the concerned teeth.
In the maxillary arch, failure of
anesthesia can occur even though not
frequently.
In the anterior teeth with long
roots, infiltration should be administered high in the vestibule (especially
canine – canine fossa). Palatal infiltration is desirable when the apices
diverge in the palatal direction [19].
Palatal infiltration is advised in
case of two-rooted premolars [19].
Palatal injection is always required for the palatal root in the maxillary
molars. Shifting from maxillary buccal
infiltrations with success rate ranging
from 62% to 100% [27] to posterior
superior alveolar nerve block (PSA)
administered behind the zygomatic
arch into the pterygomaxillary space
or anterior or middle superior alveolar
is not sufficient without an infiltration
over the mesiobuccal root. The injection is characterized by a slow onset,
and a declining duration of pulpal
anesthesia over 60 minutes would not
ensure predictable pulpal anesthesia
(28).
Cross innervations from the contralateral nerves have been implicated in
failure to achieve anesthesia in anterior teeth (incisors) in both upper and
lower jaws.
Neither increasing the volume of
the local anesthetic nor the concentration of anesthetic molecules in cases
of a hot tooth showed any advantages.
Many theories have been suggested
but none is adopted or proved correct.
- The central core theory: outer nerves
supply the molar teeth, while they
lie deeper at the anterior teeth,
which explain the difficulty in achieving successful anesthesia for mandibular anterior teeth.
-
Ion trapping: lowered pH in the
inflamed tissue reduces the amount
of the base form of the anesthetic needed to penetrate the nerve
sheath and membrane. This is true
in local anesthetics and not in IANB
injection given at distance from
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the area of inflammation (the hot
tooth).
Altered membrane excitability: The
inflamed nerves arising from the tissues have altered resting potentials
and lowered excitability thresholds,
and thereby not preventing the transmission of nerve impulses.
Tetrodotoxin resistant channels
(TTX-R): Increased expression of
sodium channels by nociceptors that
are resistant to anesthetic due to upregulation in pulps diagnosed with IP
[29].
No matter what causes the failure
of anesthesia, when patient complaints
of severe pain during the treatment
procedure, the dentists/endodontists
try to achieve a profound anesthesia
and to obtain a sufficient working time
using supplemental injections such as
the periodontal ligament (PDL) injection, the intraosseous injection and
the intrapulpal injection.
Mandibular buccal infiltration in IANB
As a supplementary injection,
mandibular buccal infiltration injection increases the success of the IANB.
Injection of 4% articaine with 1:100,000
epinephrine in asymptomatic patients
reported a success rate of 91% [30].
Another study by Matthews testing
buccal infiltration as a supplement in
patients diagnosed with IP reported a
success of only 58% [31]. This result
was much less than the success attained with the IO and PDL injections.
Intrapulpal injection
Intrapulpal injection is a prime
indication and the last resort when failure to produce adequate anesthesia.
However, this technique requires the
exposition of the pulp tissue. Pulpal
exposure could be a painful procedure. Simply placing local anesthetic
solution in the pulp chamber will not
achieve adequate pulpal anesthesia;
a strong back-pressure induces an
immediate effect and a rapid onset
[32]. The working time is of short duration (approximately15–20 minutes).
The dentist should act quickly to

remove all the tissue from the pulp
chamber and debride the canals.
Before performing the intrapulpal
anesthesia, the patient is warned of
a moderate to severe pain during the
initial phase, a pain that will last no
more than one to two seconds. The
relief occurs the instant the pain is
perceived. The use of a small round bur
to access quickly the pulp chamber is
necessary to be able to introduce the
needle.
Intraligamentary (periodontal
ligament) injection
The periodontal ligament (PDL)
additional injection is still one of the
most widely taught and used supplemental techniques. In patients with IP,
injections were successful 74% of the
time, whereas reinjection boosted success to 96%. To avoid failure and to get
successful PDL injection, the dentist
should apply backpressure during the
injection. PDL injections are usually
given using either a standard dental
anesthetic syringe or a high-pressure
syringe [33]. Using the CompuDent
(originally known as Wand system),
primary PDL injection was successful
86% of the time with 4% articaine with
1:100,000 epinephrine and 74% of the
time with 2% lidocaine with 1:100,000
epinephrine. No significant difference
was found between the two solutions.
The system was able to deliver 1.4 ml
in approximately 4 minutes 45 seconds
as slow rate or in one minute as fast
rate of the anesthetic over the course
of the injection. The duration of the
anesthesia for the first molar averaged
from 31 to 34 minutes [34]. The amount
differs significantly from the periodontal ligament injection with a conventional syringe or pressure syringe.
This technique presents many limitations such as:
- Bacteremia in endocarditis;
- Cardio-vascular effects;
- Discomfort due to injection;
- Damage to periodontal tissues.
Intraosseous injection (IO)
It’ the only technique that allows the
practitioner to deliver local anesthe-

tic solutions directly into the cancellous bone surrounding the concerned
tooth. It improves the anesthetic efficacy of the IANB in mandibular posterior teeth with irreversible IP.
Success of IO in achieving pulpal
anesthesia in patients with IP has been
reported to be 82-98% [15] and 83.33%
[35].
There are several available IO systems: Stabident system (Fairfax Dental
Inc., Miami) (Fig. 1), X-tip system (X-tip
Technologies, Dentsply, Maillefer) (Fig.
2), IntraFlow (Intra Vantage, Plymouth,
MN), the Comfort Control Syringe®
(Dentsply International, York, PA)
and the Quicksleeper (DHT, Cholet,
France).
All devices consist of a 27-gauge
needle driven by a slow-speed air
motor handpiece (Fig. 3).
The injection should be done distal to the tooth in question with the
only exception at the maxillary and
mandibular second molars, for which a
mesial site injection would be needed
[35].
The perforation site is selected
2-4 mm apical to the alveolar crestal
bone level in the attached gingiva to
allow a minimal thickness of tissue
and cortical bone. The level of crestal
bone is determined by sounding with a
periodontal probe. In 2-4 seconds, the
drill perforates a small hole through
the cortical plate into the cancellous
bone. The needle perforates the cortical bone in order to deliver a standard
anesthetic syringe into the cancellous
bone. The solution is delivered over a
1 minute time period after administration of anesthetic solution, the guide
sleeve is removed using a hemostat.
Results have shown success rate
up to 98% in attaining complete pulpal
anesthesia especially when a second
IO injection is delivered.
The advantages of this technique are:
- Immediate onset of anesthesia [7].
- Higher successful rates than periodontal injection due to the greater amount delivered of anesthetic
solution.
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Fig. 1: Stabident perforator, a solid 27-gauge
wire with a beveled end that is placed in a
slow-speed handpiece.

Fig. 2: The X-tip delivery system made of an
X-tip (top)that separates into two parts: the
drill (a special hollow needle) and the guide
sleeve component.

Fig. 3: Intraosseous injection using the X-tip system.

- Shorter duration of anesthesia compared to mandibular block or infiltration [6].
However, this technique presents
cardiovascular risks with the rapid
entry of anesthetic and vasoconstrictor
causing tachycardia [6].
In both the IO and the PDL injections, the dentist should respect these
obligations:
-
Administration of the minimum
quantity needed to assure profound
anesthesia.
-
No injection and anesthesia delivery into an actively acute abscess
site.
- Differentiate IP from a symptomatic
necrotic tooth with apical pathosis
since, in this condition, intraosseous and intrapulpal injections
may not be effective and there exists
the possibility of forcing bacteria
into the periradicular tissues.

Conclusion
Achieving
adequate
pulpal
anesthesia in patients diagnosed with
an irreversible pulpitis is a great challenge. When the inferior alveolar nerve
block fails to provide profound pulpal
anesthesia, it is necessary for the clinician to develop a plan to deal with
failures. This plan needs to include
different approaches, skills and mastering supplemental techniques like
the PDL or the IO injections proven
effective in achieving pulpal anesthesia under such conditions. The main
objective is to provide relatively painfree treatment.
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